)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Novakand Pharma
Novakand Pharma (NOVKAN) investor relations material
Novakand Pharma Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary20 Feb, 2026
Executive summary
Entered a non-binding letter of intent for a reverse acquisition of SVF Vaccines AB, to be paid with newly issued shares.
Nasdaq placed the company on its observation list due to non-compliance with operational requirements, requiring action within four months to avoid delisting.
After the period, a definitive acquisition agreement with SVF Vaccines was signed, pending EGM and regulatory approvals.
The company’s main activities focused on preparing for the reverse acquisition and evaluating potential partners for its fraktalkin program.
Financial highlights
Q4 operating loss was -5.0 MSEK (vs. -9.9 MSEK YoY); full-year operating loss before impairments was -29.6 MSEK (vs. -46.2 MSEK YoY).
Net result after financial items for Q4 was -5.0 MSEK (vs. -9.6 MSEK YoY); full-year net result after impairment was -47.2 MSEK (vs. -44.6 MSEK YoY).
R&D expenses for Q4 were 3.5 MSEK (vs. 8.5 MSEK YoY); full-year R&D was 23.6 MSEK (vs. 40.0 MSEK YoY).
Cash flow from operations for Q4 was -6.2 MSEK (vs. -11.6 MSEK YoY); full-year was -30.3 MSEK (vs. -58.5 MSEK YoY).
Equity at year-end was 15.1 MSEK (vs. 62.3 MSEK YoY); cash at year-end was 16.1 MSEK (vs. 46.4 MSEK YoY).
Outlook and guidance
The board sees the reverse acquisition as the best option for shareholder value, given the challenges in raising capital for further clinical development.
The transaction is expected to close by the end of Q1 2026, subject to EGM and regulatory approvals.
If the transaction fails, there is a risk of delisting and potential liquidation, which would significantly erode shareholder value.
What if Nasdaq denies merged entity listing?
Will fractalkine program be actively developed?
What is the operational plan if acquisition fails?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Novakand Pharma earnings date
Q1 202622 May, 2026
Novakand Pharma
Next Novakand Pharma earnings date
Q1 202622 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Kancera AB is a Swedish biotechnology company focusing on developing pharmaceuticals for the treatment of severe diseases, particularly cancer and inflammatory conditions. The company's efforts are primarily directed towards creating small molecule drug candidates that target disease-promoting immune and cancer cells, specifically utilizing the fractalkine axis. Kancera's work is divided into two main areas: Pharmaceutical Development and Industrial Research and Development (R&D). Solna, Stockholm, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage